(Q38025346)

27 August 2017

title

Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades (English)

1 reference

27 August 2017

0 references

Thomas B Shea

1

1 reference

27 August 2017

Ruth Remington

series ordinal

2

1 reference

27 August 2017

publication date

11 July 2012

1 reference

Journal of Neural Transmission

27 August 2017

published in

1 reference

27 August 2017

volume

119

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1529-1532

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-012-0849-0

27 August 2017

exact match

0 references

cites work

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Negative argument for debate with V. O. Emery for J Neural Transmission : Alzheimer's disease: are we intervening too late? No we are not. Con.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Nonpharmacological treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Integrated treatment approach improves cognitive function in demented and clinically depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Risk factors and preventive interventions for Alzheimer disease: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Alzheimer disease: are we intervening too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

A randomized trial of vitamin E supplementation and cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Physical activity and diabetes prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Evolution of the diagnostic criteria for degenerative and cognitive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

A potential design flaw of randomized trials of vitamin supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: evidence from a nationally representative sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Mediterranean diet in predementia and dementia syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Cobalamin deficiency, hyperhomocysteinemia, and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Oxidative stress signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0849-0

Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice

21 January 2018

1 reference

12 December 2020

gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells.

1 reference

12 December 2020

S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice.

1 reference

12 December 2020

A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners

1 reference

12 December 2020

Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment

1 reference

12 December 2020

A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes

1 reference

12 December 2020

Epigenetics, oxidative stress, and Alzheimer disease

1 reference

12 December 2020

Vitamin B12 and folate depletion in cognition: a review.

1 reference

12 December 2020

The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?

1 reference

12 December 2020

Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial

1 reference

12 December 2020

S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00702-012-0849-0

Identifiers

DOI

1 reference

27 August 2017

1 reference